Tags

Type your tag names separated by a space and hit enter

Knowledge and use of folic acid supplementation: a study of Colorado women whose pregnancies were affected by a fetal neural tube defect.
Clin Invest Med. 2001 Jun; 24(3):124-8.CI

Abstract

OBJECTIVES

To determine whether women who have ha da pregnancy in which the fetus is affected by a neural tube defect (NTD) know of current folic acid recommendations; whether the recommendations are followed before or during the pregnancy associated with an NTD and subsequent pregnancies; and to insure that women who have had an NTD-affected pregnancy have access to proper information about NTDs and folic acid recommendations.

METHODS

Women living in Colorado who had a pregnancy in 1996 or 1997 in which the fetus had an NTD were interviewed in 1998 about their knowledge and use of folic acid supplementation.

RESULTS

Twenty-one of 42 eligible women were interviewed. All women first learned of the folic acid recommendations either during or after their affected pregnancy. Only 23.8% of the women took vitamins containing folic acid during the 1 to 3 months before becoming pregnant. None who had a subsequent pregnancy followed the recommendation to consume 4.0 mg/d of folic acid, beginning at least 1 month before conception. Women who had subsequent pregnancies became pregnant on average of 9 months after their affected pregnancy ended.

CONCLUSIONS

Most women who have an NTD-affected pregnancy are unaware of the national folic acid recommendations and do not follow these recommendations for subsequent pregnancies. However, such women are receptive to information about folic acid supplementation. Health care providers and public health officials should consider their role in assuring that education is provided in an effective and timely manner to women with NTD-affected pregnancies.

Authors+Show Affiliations

Callender ES
University of Colorado Health Sciences Center, Denver, USA. elizabeth.callender@uchsc.edu
Rickard R
No affiliation info available
Miller L
No affiliation info available
Rinsky-Eng J
No affiliation info available

MeSH

AdolescentAdultColoradoContinental Population GroupsDietary SupplementsFemaleFolic AcidHealth Knowledge, Attitudes, PracticeHumansNeural Tube DefectsPatient Education as TopicPregnancySurveys and Questionnaires

Pub Type(s)

Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

11437063

Citation

Callender, E S., et al. "Knowledge and Use of Folic Acid Supplementation: a Study of Colorado Women Whose Pregnancies Were Affected By a Fetal Neural Tube Defect." Clinical and Investigative Medicine. Medecine Clinique Et Experimentale, vol. 24, no. 3, 2001, pp. 124-8.
Callender ES, Rickard R, Miller L, et al. Knowledge and use of folic acid supplementation: a study of Colorado women whose pregnancies were affected by a fetal neural tube defect. Clin Invest Med. 2001;24(3):124-8.
Callender, E. S., Rickard, R., Miller, L., & Rinsky-Eng, J. (2001). Knowledge and use of folic acid supplementation: a study of Colorado women whose pregnancies were affected by a fetal neural tube defect. Clinical and Investigative Medicine. Medecine Clinique Et Experimentale, 24(3), 124-8.
Callender ES, et al. Knowledge and Use of Folic Acid Supplementation: a Study of Colorado Women Whose Pregnancies Were Affected By a Fetal Neural Tube Defect. Clin Invest Med. 2001;24(3):124-8. PubMed PMID: 11437063.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Knowledge and use of folic acid supplementation: a study of Colorado women whose pregnancies were affected by a fetal neural tube defect. AU - Callender,E S, AU - Rickard,R, AU - Miller,L, AU - Rinsky-Eng,J, PY - 2001/7/5/pubmed PY - 2002/1/5/medline PY - 2001/7/5/entrez SP - 124 EP - 8 JF - Clinical and investigative medicine. Medecine clinique et experimentale JO - Clin Invest Med VL - 24 IS - 3 N2 - OBJECTIVES: To determine whether women who have ha da pregnancy in which the fetus is affected by a neural tube defect (NTD) know of current folic acid recommendations; whether the recommendations are followed before or during the pregnancy associated with an NTD and subsequent pregnancies; and to insure that women who have had an NTD-affected pregnancy have access to proper information about NTDs and folic acid recommendations. METHODS: Women living in Colorado who had a pregnancy in 1996 or 1997 in which the fetus had an NTD were interviewed in 1998 about their knowledge and use of folic acid supplementation. RESULTS: Twenty-one of 42 eligible women were interviewed. All women first learned of the folic acid recommendations either during or after their affected pregnancy. Only 23.8% of the women took vitamins containing folic acid during the 1 to 3 months before becoming pregnant. None who had a subsequent pregnancy followed the recommendation to consume 4.0 mg/d of folic acid, beginning at least 1 month before conception. Women who had subsequent pregnancies became pregnant on average of 9 months after their affected pregnancy ended. CONCLUSIONS: Most women who have an NTD-affected pregnancy are unaware of the national folic acid recommendations and do not follow these recommendations for subsequent pregnancies. However, such women are receptive to information about folic acid supplementation. Health care providers and public health officials should consider their role in assuring that education is provided in an effective and timely manner to women with NTD-affected pregnancies. SN - 0147-958X UR - https://www.unboundmedicine.com/medline/citation/11437063/Knowledge_and_use_of_folic_acid_supplementation:_a_study_of_Colorado_women_whose_pregnancies_were_affected_by_a_fetal_neural_tube_defect_ L2 - https://medlineplus.gov/neuraltubedefects.html DB - PRIME DP - Unbound Medicine ER -